These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15106423)

  • 1. [Enteropathy induced by nonsteroid anti-inflammatory drugs].
    Karateev AE; Nasonova VA
    Ter Arkh; 2004; 76(2):79-82. PubMed ID: 15106423
    [No Abstract]   [Full Text] [Related]  

  • 2. [Unsolved problems of enteropathy induced by nonsteroidal anti-inflammatory drugs].
    Murav'ev IuV; Lebedeva VV
    Ter Arkh; 2009; 81(2):90-3. PubMed ID: 19334501
    [No Abstract]   [Full Text] [Related]  

  • 3. [Can gastroduodenal lesions induced by non-steroidal anti-inflammatory agents be prevented?].
    Florent C; Florent M; Desaint B
    Rev Med Suisse Romande; 1992 Jun; 112(6):497-500. PubMed ID: 1631460
    [No Abstract]   [Full Text] [Related]  

  • 4. Gastrointestinal events related to the use of non-steroidal anti-inflammatory drugs: some clinical and economic aspects.
    Eliakim R; Rachmilewitz D
    Isr J Med Sci; 1997 Oct; 33(10):696-9. PubMed ID: 9397147
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessment and prevention of gastrointestinal toxicity of non-steroidal anti-inflammatory drugs.
    Lane ME; Kim MJ
    J Pharm Pharmacol; 2006 Oct; 58(10):1295-304. PubMed ID: 17034651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gastropathy by NSAID].
    Pérez Manauta J
    Rev Gastroenterol Mex; 2005 Nov; 70 Suppl 3():24-5. PubMed ID: 17471850
    [No Abstract]   [Full Text] [Related]  

  • 7. [When and why should we eradicate the Helicobacter pylori?].
    Perez Perez GI
    Rev Gastroenterol Mex; 2005 Nov; 70 Suppl 3():26-7. PubMed ID: 17471851
    [No Abstract]   [Full Text] [Related]  

  • 8. [Epidemiology study on upper gastrointestinal lesions induced by non-steroidal anti-inflammatory drugs].
    Shiokawa Y; Nobunaga M; Saito T; Asaki S; Ogawa N
    Ryumachi; 1991 Feb; 31(1):96-111. PubMed ID: 1858000
    [No Abstract]   [Full Text] [Related]  

  • 9. Upper gastrointestinal symptoms and therapies in elderly out-patients, users of non-selective NSAIDs or coxibs.
    Pilotto A; Franceschi M; Vitale DF; Zaninelli A; Masotti G; Rengo F; ;
    Aliment Pharmacol Ther; 2005 Jul; 22(2):147-55. PubMed ID: 16011673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nonsteroidal anti-inflammatory agents and gastrointestinal pathology].
    Lanas AI
    Gastroenterol Hepatol; 1995 Mar; 18(3):142-52. PubMed ID: 7621292
    [No Abstract]   [Full Text] [Related]  

  • 11. Complications of NSAID gastropathy and use of gastric cytoprotection: experience at a tertiary care health center.
    Berthelot JM; Maugars Y
    J Rheumatol; 2000 May; 27(5):1322. PubMed ID: 10813313
    [No Abstract]   [Full Text] [Related]  

  • 12. Overview of 50 years' progress in upper gastrointestinal diseases.
    Yeomans ND
    J Gastroenterol Hepatol; 2009 Oct; 24 Suppl 3():S2-4. PubMed ID: 19799693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epidemiology of lesions caused by non-steroidal anti-inflammatory agents].
    De Angelis C; Rizzetto M; Pera A
    Minerva Gastroenterol Dietol; 1992; 38(1):27-40. PubMed ID: 1520751
    [No Abstract]   [Full Text] [Related]  

  • 14. [Gastropathy induced by nonsteroidal anti-inflammatory drugs (Part II)].
    Nasonov EL; Karateev AE
    Klin Med (Mosk); 2000; 78(4):4-9. PubMed ID: 10833880
    [No Abstract]   [Full Text] [Related]  

  • 15. Gastrointestinal tract disorder as a side effect of non-steroidal anti inflammatory drugs (NSAIDs).
    Simadibrata M
    Acta Med Indones; 2004; 36(4):195-6. PubMed ID: 15931719
    [No Abstract]   [Full Text] [Related]  

  • 16. [Enteropathy induced by nonsteroid anti-inflammatory drugs: pathogenesis, diagnosis, treatment].
    Ter Arkh; 2012; 84(5):74-9. PubMed ID: 22830218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.
    Chan FK; Graham DY
    Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upper gastrointestinal tolerability of once weekly alendronate 70 mg with concomitant non-steroidal anti-inflammatory drug use.
    Cryer B; Miller P; Petruschke RA; Chen E; Geba GP; Papp AE
    Aliment Pharmacol Ther; 2005 Mar; 21(5):599-607. PubMed ID: 15740544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of non steroidal anti-inflammatory drug induced gastro-intestinal damage.
    McCormack PM
    Ir Med J; 1994; 87(2):27-8. PubMed ID: 8194941
    [No Abstract]   [Full Text] [Related]  

  • 20. [Gastrointestinal complications of non-steroid anti-inflammatory drugs (NSAID): problems to be solved. Rheumatologist's expert opinion].
    Nasonov EL; Karateev AE
    Eksp Klin Gastroenterol; 2006; (2):6-9. PubMed ID: 16866255
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.